NCT06138912 is a clinical trial of plain radiography (x-ray) in Spinal Curvatures, sponsored by Chonnam National University Hospital.

Who is sponsoring NCT06138912?

NCT06138912 is sponsored by Chonnam National University Hospital.

What drugs are being tested in NCT06138912?

Interventions in NCT06138912: plain radiography (x-ray).

What condition does NCT06138912 study?

NCT06138912 studies Spinal Curvatures.

Is NCT06138912 still recruiting?

NCT06138912 is currently completed. Last updated 18 November 2023.

Last reviewed 2023-11-18 · How we verify

NCT06138912

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Thoracolumbar Junction

Completed Last updated 18 November 2023

What this trial tests

trial testing plain radiography (x-ray) in Spinal Curvatures in 120 participants. Completed in 31 December 2021.

Timeline

3 January 2020

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	Chonnam National University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	120
Start date	3 January 2020
Primary completion	31 December 2021
Estimated completion	31 December 2021
Sites	1 location across South Korea

Drugs / interventions tested

plain radiography (x-ray)

Conditions studied

Spinal Curvatures — all drugs for Spinal Curvatures →

Sponsor

Chonnam National University Hospital

Who can join

Adults 20 to 78, any sex, with Spinal Curvatures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Several studies have investigated the mechanical behavior of the thoracolumbar spine. However, an accurate reference for normal functional local alignment and segmental motion at the thoracolumbar junction is still illusive. Therefore, we conducted a cross-sectional cohort study with a balanced distribution of age and sex of healthy subjects to examine the normal alignment and segmental motion at the thoracolumbar junction using dynamic plain radiography. This study aimed to provide data that can be used when planning surgery or performing rehabilitation in pathological situations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Chonnam National University Hospital trials

Trials by the same sponsor.

NCT07390461 — Effectiveness of Artificial Intelligence Integrated Mixed Reality-based High-Alert Medications Management Simulation Pro · NA · not yet recruiting
NCT07482228 — Long-term Clinical Outcomes After Retinal Artery Occlusion · recruiting
NCT06954714 — Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions · NA · recruiting
NCT07002164 — Timing of Coronary Angiography in NSTEMI Complicated by Acute HF · NA · recruiting
NCT06227754 — OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06138912 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chonnam National University Hospital
Last refreshed: 18 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06138912.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing